• Login
    View Item 
    •   UCUDIR Home
    • Research Papers and Publications
    • UCU School of Medicine
    • View Item
    •   UCUDIR Home
    • Research Papers and Publications
    • UCU School of Medicine
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Association of aging and survival in a large HIV-infected cohort on antiretroviral therapy

    Thumbnail
    View/Open
    The final, definitive version of this paper has been published in the AIDS, Vol.25, No 5, March/2011. DOI: 10.1097/QAD.0b013e3283437ed7; published by Wolters Kluwer Health | Lippincott Williams & Wilkins. All rights reserved. (230.9Kb)
    Date
    2011-03
    Author
    Bakanda, Celestin
    Birungi, Josephine
    Mwesigwa, Robert
    Ford, Nathan
    Cooper, Curtis L.
    Au-Yeung, Christopher
    Chan, Keith
    Nachega, Jean B.
    Wood, Evan
    Hogg, Robert S.
    Dybul, Mark
    Mills, Edward J.
    Metadata
    Show full item record
    Abstract
    Objective: To examine if there is a significant difference in survival between elderly (>50 years) and nonelderly adult patients receiving combination antiretroviral therapy in Uganda between 2004 and 2010. Design: Prospective observational study. Methods: Patients 18–49 years of age (nonelderly) and 50 years of age and older enrolled in the AIDS Support Organization Uganda HIV/AIDS national programme were assessed for time to all-cause mortality. We applied a Weibull multivariable regression. Results: Among the 22 087 patients eligible for analyses, 19 657 (89.0%) were aged between 18 and 49 years and 2430 (11.0%) were aged 50 years or older. These populations differed in terms of the distributions of sex, baseline CD4 cell count and death. The age group 40–44 displayed the lowest crude mortality rate [31.4 deaths per 1000 person-years; 95% confidence interval (CI) 28.1, 34.7) and the age group 60–64 displayed the highest crude mortality rate (58.9 deaths per 1000 person-years; 95% CI 42.2, 75.5). Kaplan–Meier survival estimates indicated that nonelderly patients had better survival than elderly patients (P < 0.001). Adjusted Weibull analysis indicated that elderly age status was importantly associated (adjusted hazard ratio 1.23, 95% CI 1.08–1.42) with mortality, when controlling for sex, baseline CD4 cell count and year of therapy initiation. Conclusion: As antiretroviral treatment cohorts mature, the proportion of patients who are elderly will inevitably increase. Elderly patients may require focused clinical care that extends beyond HIV treatment.
    Use this URI to cite this item:
    https://hdl.handle.net/20.500.11951/302
    Collections
    • UCU School of Medicine [158]

    UCUDIR copyright © 2017-2019  UCU Library |  Search Library Catalogue
    Contact Us | Send Feedback
     
    Atmire NV
     

     

    Browse

    All of UCUDIRCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

    My Account

    LoginRegister

    UCUDIR copyright © 2017-2019  UCU Library |  Search Library Catalogue
    Contact Us | Send Feedback
     
    Atmire NV